Takami Sato
Elite in Melanoma

Dr. Takami Sato

Hematology | Oncology
Jefferson Health
111 South 11th Street, The Bodine Center, 
Philadelphia, PA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Elite in Melanoma
Jefferson Health
111 South 11th Street, The Bodine Center, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Takami Sato is an Oncologist in Philadelphia, Pennsylvania. Dr. Sato is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Liver Embolization, and Osteotomy. Dr. Sato is currently accepting new patients.

His clinical research consists of co-authoring 99 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 78 articles and participated in 6 clinical trials in the study of Melanoma.

Graduate Institution
Jichi Medical School
Residency
Oita Prefectural Hospital
Specialties
Hematology
Oncology
Licenses
Internal Medicine in PA
Fellowships
Jichi Medical School
Hospital Affiliations
Thomas Jefferson University Hospital
Languages Spoken
English
Japanese
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
View 5 Less Insurance Carriers -

Locations

111 South 11th Street, The Bodine Center, Philadelphia, PA 19107
Call: 215-955-8874
Other Locations
Jefferson Cancer - Honickman Center
1101 Chestnut Street, Floor 14, Philadelphia, PA 19107
Call: 215-955-8874

Additional Areas of Focus

Dr. Sato has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Melanoma
Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Phase 1/2 Study of IMC-F106C in Advance PRAME-Positive Cancers
Phase 1/2 Study of IMC-F106C in Advance PRAME-Positive Cancers
Enrollment Status: Recruiting
Publish Date: July 25, 2025
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
An Open-Label, Single Institution, Phase II Study Using Radioactive Yttrium90 Microsphere (SIR-Sphere®) in Uveal Melanoma Patients With Hepatic Metastasis
An Open-Label, Single Institution, Phase II Study Using Radioactive Yttrium90 Microsphere (SIR-Sphere®) in Uveal Melanoma Patients With Hepatic Metastasis
Enrollment Status: Completed
Publish Date: November 14, 2025
Intervention Type: Device
Study Phase: Phase 2
A Phase II Trial of Defactinib (VS-6063) Combined With VS-6766 (CH5126766) in Patients With Metastatic Uveal Melanoma
A Phase II Trial of Defactinib (VS-6063) Combined With VS-6766 (CH5126766) in Patients With Metastatic Uveal Melanoma
Enrollment Status: Terminated
Publish Date: July 15, 2025
Intervention Type: Drug, Procedure
Study Drugs: Defactinib Hydrochloride, Raf/MEK Inhibitor VS-6766
Study Phase: Phase 2
An Exploratory Study to Investigate the Immunomodulatory Activity of Radiation Therapy (RT) in Combination With MK-3475 in Patients With Recurrent/Metastatic Head and Neck, Renal Cell Cancer, Melanoma and Lung Cancer
An Exploratory Study to Investigate the Immunomodulatory Activity of Radiation Therapy (RT) in Combination With MK-3475 in Patients With Recurrent/Metastatic Head and Neck, Renal Cell Cancer, Melanoma and Lung Cancer
Enrollment Status: Completed
Publish Date: May 15, 2025
Intervention Type: Radiation, Drug
Study Drug: MK-3475
Study Phase: Phase 1
A Phase I/II Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Using the Intra-patient Escalation Dosing Regimen in Patients With Advanced Uveal Melanoma
A Phase I/II Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Using the Intra-patient Escalation Dosing Regimen in Patients With Advanced Uveal Melanoma
Enrollment Status: Completed
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: IMCgp100
Study Phase: Phase 1/Phase 2
A Phase I/II Study of IMCnyeso, HLA- A*0201-Restricted, NY-ESO-1- and LAGE-1A-specific Soluble T Cell Receptor and Anti-CD3 Bispecific Molecule, in HLA-A*0201 Positive Patients With Advanced NY-ESO-1 and/or LAGE - 1A Positive Cancer
A Phase I/II Study of IMCnyeso, HLA- A*0201-Restricted, NY-ESO-1- and LAGE-1A-specific Soluble T Cell Receptor and Anti-CD3 Bispecific Molecule, in HLA-A*0201 Positive Patients With Advanced NY-ESO-1 and/or LAGE - 1A Positive Cancer
Enrollment Status: Terminated
Publish Date: March 11, 2022
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Feasibility Study of Sequential Hepatic Internal Radiation and Systemic Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastatic to Liver.
A Feasibility Study of Sequential Hepatic Internal Radiation and Systemic Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastatic to Liver.
Enrollment Status: Unknown
Publish Date: April 19, 2021
Intervention Type: Drug, Device
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 1/Phase 2
An Open-label, Phase 1B Study of NEO-PV-01 + CD40 Agonist Antibody (APX005M) or Ipilimumab With Nivolumab in Patients With Advanced or Metastatic Melanoma
An Open-label, Phase 1B Study of NEO-PV-01 + CD40 Agonist Antibody (APX005M) or Ipilimumab With Nivolumab in Patients With Advanced or Metastatic Melanoma
Enrollment Status: Terminated
Publish Date: September 03, 2020
Intervention Type: Biological, Other
Study Phase: Phase 1
View 7 Less Clinical Trials

99 Total Publications

Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients.
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 12, 2025
View All 99 Publications
Similar Doctors
Lynn M. Schuchter
Elite in Melanoma
Dr. Lynn M. Schuchter
Oncology
Elite in Melanoma
Dr. Lynn M. Schuchter
Oncology

Abramson Cancer Center Perelman 3rd Floor West

3400 Civic Center Boulevard, West Pavilion, 3rd Floor, 
Philadelphia, PA 
 (1.9 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lynn Schuchter is an Oncologist in Philadelphia, Pennsylvania. Dr. Schuchter is rated as a Distinguished provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Melanoma of the Eye, Squamous Cell Skin Carcinoma, and Merkel Cell Carcinoma. Dr. Schuchter is currently accepting new patients.

Elite in Melanoma
Dr. Ravi K. Amaravadi
Oncology
Elite in Melanoma
Dr. Ravi K. Amaravadi
Oncology

Abramson Cancer Center Perelman 3rd Floor West

3400 Civic Center Boulevard, West Pavilion, 3rd Floor, 
Philadelphia, PA 
 (1.9 miles away)
215-615-5858
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ravi Amaravadi is an Oncologist in Philadelphia, Pennsylvania. Dr. Amaravadi is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Colorectal Cancer, Tissue Biopsy, and Liver Embolization. Dr. Amaravadi is currently accepting new patients.

Anthony J. Olszanski
Elite in Melanoma
Dr. Anthony J. Olszanski
Oncology | Transplant Surgery
Elite in Melanoma
Dr. Anthony J. Olszanski
Oncology | Transplant Surgery

Temple Faculty Practice Plan Inc

3401 N Broad St, 
Philadelphia, PA 
 (3.8 miles away)
215-707-5030
Languages Spoken:
English
See accepted insurances

Anthony Olszanski is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Olszanski is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and ALK-Positive Non-Small Cell Lung Cancer.

VIEW MORE MELANOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sato's expertise for a condition
ConditionClose
  • Elite
  • Melanoma
    Dr. Sato is
    Elite
    . Learn about Melanoma.
    See more Melanoma experts
  • Melanoma of the Eye
    Dr. Sato is
    Elite
    . Learn about Melanoma of the Eye.
    See more Melanoma of the Eye experts
  • Metastatic Uveal Melanoma
    Dr. Sato is
    Elite
    . Learn about Metastatic Uveal Melanoma.
    See more Metastatic Uveal Melanoma experts
  • Uveal Melanoma
    Dr. Sato is
    Elite
    . Learn about Uveal Melanoma.
    See more Uveal Melanoma experts
    • Advanced
    • Brain Tumor
      Dr. Sato is
      Advanced
      . Learn about Brain Tumor.
      See more Brain Tumor experts
    • Glioma
      Dr. Sato is
      Advanced
      . Learn about Glioma.
      See more Glioma experts
    • Liver Cancer
      Dr. Sato is
      Advanced
      . Learn about Liver Cancer.
      See more Liver Cancer experts
    • Liver Embolization
      Dr. Sato is
      Advanced
      . Learn about Liver Embolization.
      See more Liver Embolization experts
    • Experienced
    • Cholangiocarcinoma (Bile Duct Cancer)
      Dr. Sato is
      Experienced
      . Learn about Cholangiocarcinoma (Bile Duct Cancer).
      See more Cholangiocarcinoma (Bile Duct Cancer) experts
    • Colonoscopy
      Dr. Sato is
      Experienced
      . Learn about Colonoscopy.
      See more Colonoscopy experts
    • Colorectal Cancer
      Dr. Sato is
      Experienced
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • Embryonal Tumor with Multilayered Rosettes
      Dr. Sato is
      Experienced
      . Learn about Embryonal Tumor with Multilayered Rosettes.
      See more Embryonal Tumor with Multilayered Rosettes experts
    • Endoscopy
      Dr. Sato is
      Experienced
      . Learn about Endoscopy.
      See more Endoscopy experts
    • Esophageal Cancer
      Dr. Sato is
      Experienced
      . Learn about Esophageal Cancer.
      See more Esophageal Cancer experts
    View All 22 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.